The most powerful programming language today isn’t written in code editors. It’s natural language. In this article, I’ll ...

FANUC America is collaborating with NVIDIA to advance the use of physical AI in industrial robotics, combining automation ...

When it comes to a boa vs python, how can you tell these two snakes a part? Read here to learn about some of their differences!

Researchers have developed an AI image generator that produces images in just four steps, rather than dozens. This could bring fast, private image generation directly to consumer devices. When you ...

View post: Target Has a 'Very Solid' $1,500 Metal Outdoor Storage Shed on Sale for 64% Off If it feels like you’re forced to deal with power outages more regularly than ever before, you aren’t just ...

This article is not about ethics, privacy, security, ownership, or corporate governance — I am going to circumvent all of this here by using some made-up data relating to supermarket sales: Here, I ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...